With $45M in Funding, Startup Voyager Therapeutics Aims to Develop

With M in Funding, Startup Voyager Therapeutics Aims to Develop
Paul confirmed that the company expects to use an RNAi approach in its ALS program, which aims to knock down the gene SOD1, and potentially with a Huntington's disease treatment, but he did not provide additional details. However, Gao … Paul said …
Read more on GenomeWeb

 

Chief Lansdowne's fatally flawed fix for drug abuse
The money saved, which they estimate at $ 150 million to $ 200 million a year, would be earmarked for drug treatment and mental health programs, crime prevention programs in schools and a fund for victims of trauma. If cleared by the state for …
Read more on U-T San Diego

 

Multiple Sclerosis (Post Date: 2/18/14)
… Anthony T. Reder, MD, professor of neurology at The University of Chicago Medicine; and Barbara Giesser, MD, vice chair of the neurology department at the University of California Los Angeles. Their answers covered drug selection, new rehab …
Read more on MedPage Today

 

Find More Drug Treatment Programs In California Information…